Hepatitis B Vaccine (Recombinant) Completed Phase 4 Trials for Viral Hepatitis B / Prophylaxis Hepatitis B

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT00329576Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine